How self-employed workers were impacted in the Autumn Statement 2023
In this article we look at the changes from the Autumn Statement 2023 that will affect self-employed workers and what these changes mean.
Pharmaceutical
With a strong presence in Cambridge and offices based across London, the East of England, and internationally, pharmaceutical companies are a core sector for Price Bailey, with clients spanning all areas of the supply chain.
Supporting the long-term success of your business
To support pharmaceutical companies, we have crafted our service offering to ensure that we can support you at whichever stage of your business lifecycle you find yourself.
Giving you the right advice to grow your business
The last couple of years has contained some of the greatest global challenges we have ever seen for numerous businesses, including pharmaceutical companies.
As a result, pharmaceutical companies have seen a rapid increase in demand to manufacture and deliver drugs to a market at an unprecedented speed. This, combined with regulatory changes, supply chain and skilled labour shortages around the world, has had a significant impact on pharmaceutical companies.
The speed at which pharmaceuticals can be brought to market is causing many to review their resources, operations, and strategies to prevent possible delays in their supply chains.
To alleviate some of the pressures that pharmaceutical companies may be facing and to allow you more headspace to focus on advancing your business, we can offer an extensive range of expert accountancy services.
As a pharmaceutical company, you may benefit in particular from:
- tax planning advice
- business structure reviews
- annual accounts
- payroll
- audit and assurance
- tax advisory
- M&A and fundraising
We can help
Contact us today to find out more about how we can help you
Read our insights here
A guide to the Enterprise Investment Scheme (EIS) for founders and investors.
Following the extension of the EIS and VCT sunset clause announced in the Government's 2023 Autumn Statement, we provide a guide to EIS for companies and investors.
Download your 2023 Autumn Statement summary
On 22 November 2023, Jeremy Hunt delivered the ‘Autumn Statement for Growth’. Our summary covers all the key points and is available to download now.
A guide to Full Expensing for British businesses
Following the announced extension and permanence of full expensing in the 2023 Autumn Statement, we provide up to date guidance on how full expensing works and its benefit to British businesses.